Definition: Slowly progressing neurologic movement disorder leading to disability.
Prevalence: Affects about 1 million patients in the U.S. annually; more common in men than women; typically diagnosed around age 50.
Cause: Unknown, possibly due to environmental or genetic factors.
Dopamine Loss:
Loss of dopamine production and storage cells in the substantia nigra leads to insufficient dopamine, affecting movement control.
Dopamine is inhibitory (slows movement), while acetylcholine is excitatory (promotes movement).
Lack of dopamine contributes to hallmark symptoms.
Progression:
Symptoms start small and worsen over time; chronic prolonged course.
Four cardinal symptoms: tremor, rigidity, bradykinesia or akinesia, and postural instability.
Subtypes:
Tremor-Dominant: Predominance of tremor with fewer other symptoms.
Nontremor Dominant: Focus on akinetic rigidity and postural instability.
Hallmark Symptoms Detail:
Tremor: Unilateral resting tremor, often resembling a pill-rolling motion.
Rigidity: Resistance to passive limb movement characterized by lead pipe or cogwheel movements.
Bradykinesia: Characterized by slowness of movement; crucial in diagnosis.
Postural Instability: Balance problems leading to gait issues, such as shuffling and propulsive gait.
Autonomic Symptoms: Include excessive sweating, drooling, orthostatic hypotension, gastric and urinary retention, and sexual dysfunction.
Psychiatric Symptoms: Commonly depression and anxiety; may progress to dementia and hallucinations.
Masked Facial Expression: Reduced ability to express facial emotions due to muscle rigidity.
Overall Progression: Documented in stages, with videos illustrating differences in symptom severity.
Fall Precautions: High fall risk due to postural instability; interventions include modifying the home environment.
Swallowing Difficulties: Increase risk of aspiration and pneumonia; recommend an upright position during meals and semi-solid diets.
Increased Fall Risk: Encourage use of assistive devices and implement safety precautions.
Cognition Monitoring: Depression and cognitive impairment need regular assessments; psychotherapeutic interventions possible.
Medications:
Dopaminergics: Levodopa and carbidopa as primary treatment; manage symptoms by increasing dopamine availability.
Adverse Effects: Long-term use may lead to dyskinesias, involuntary movements that interfere with daily living.
Other Drug Classes: Include dopamine agonists, anticholinergics, COMT inhibitors, MAOIs, and antivirals.
Surgical Procedures:
Deep Brain Stimulation (DBS): Implanting electrodes to stimulate dopamine production areas; may allow reduction of medication doses.
Ablative Procedures: Thalamotomy and pallidotomy less common due to risks.
Medication Administration: Regular dosages tailored to patient response.
Monitoring and Support: Assess swallowing, nutrition, mobility, and mental status; work closely with speech and occupational therapy.
Dietary Needs: Encourage small, frequent meals and high-calorie foods to combat weight loss due to difficulties in eating.
Mobility Enhancement: Regular exercise and physical therapy to stimulate muscle strength and balance.
Communication Strategies: Remind patients to speak clearly and face listeners, utilize speech therapy for specific exercises.
Definition: Chronic autoimmune disorder affecting the central nervous system (CNS).
Pathophysiology: Demyelination leads to impaired nerve transmission; plaques observed in MRIs.
Prevalence: More common in women (ages 20-40) and in northern regions, with known risk factors including obesity and low vitamin D exposure.
Relapsing-Remitting (RRMS): Most common type; fluctuating periods of symptoms.
Secondary Progressive: Progresses from RRMS to a steady decline without clear remissions.
Primary Progressive: Constant symptoms without relapse and remission phases.
Progressive Relapsing: A continuous decline with intermittent exacerbations.
Common Symptoms: Fatigue, muscle weakness, ataxia, vision changes, pain, and cognitive/psychological issues.
Fatigue: Considered the most debilitating symptom; management through treating underlying causes.
Visual Changes: Such as blurred vision and diplopia.
Motor Symptoms: May lead to complications like pressure injuries and osteoporosis due to immobility.
MRI Findings: Identification of plaques in CNS.
Cerebrospinal Fluid Analysis: Detects oligoclonal banding, indicating an immune response.
Disease-Modifying Drugs: Aim to reduce relapses and plaques, primarily for non-primary progressive types.
Symptomatic Treatments: Include medications for fatigue, pain, and spasticity, as well as therapies for improving function and mobility.
Promote Mobility: Regular physical therapy and support with assistive devices.
Nutrition Management: Address weight gain or loss; educate families on meal preparation suitable for patients.
Fatigue Management: Advocate for proper sleep hygiene and energy conservation techniques.
Definition: Slowly progressing neurologic movement disorder leading to disability.
Prevalence: Affects about 1 million patients in the U.S. annually; more common in men than women; typically diagnosed around age 50.
Cause: Unknown, possibly due to environmental or genetic factors; some studies suggest exposure to pesticides or head injuries may increase risk.
Dopamine Loss:
Loss of dopamine production and storage cells in the substantia nigra leads to insufficient dopamine, affecting movement control.
Dopamine is inhibitory (slows movement), while acetylcholine is excitatory (promotes movement).
Lack of dopamine contributes to hallmark symptoms.
Neuroinflammation may also play a role in the progression of the disease.
Progression:
Symptoms start small and worsen over time; chronic prolonged course.
Four cardinal symptoms: tremor, rigidity, bradykinesia or akinesia, and postural instability.
Subtypes:
Tremor-Dominant: Predominance of tremor with fewer other symptoms.
Nontremor Dominant: Focus on akinetic rigidity and postural instability.
Hallmark Symptoms Detail:
Tremor: Unilateral resting tremor, often resembling a pill-rolling motion.
Rigidity: Resistance to passive limb movement characterized by lead pipe or cogwheel movements.
Bradykinesia: Characterized by slowness of movement; crucial in diagnosis.
Postural Instability: Balance problems leading to gait issues, such as shuffling and propulsive gait.
Additionally, loss of automatic movements such as blinking or arm swinging during walking may occur.
Autonomic Symptoms: Include excessive sweating, drooling, orthostatic hypotension, gastric and urinary retention, and sexual dysfunction.
Psychiatric Symptoms: Commonly depression and anxiety; may progress to dementia and hallucinations.
Masked Facial Expression: Reduced ability to express facial emotions due to muscle rigidity.
Sleep Disturbances: Insomnia and changes in sleep architecture can exacerbate fatigue and cognitive issues.
Overall Progression: Documented in stages, with videos illustrating differences in symptom severity.
Fall Precautions: High fall risk due to postural instability; interventions include modifying the home environment; physical therapy can help improve balance and stability.
Swallowing Difficulties: Increase risk of aspiration and pneumonia; recommend an upright position during meals and semi-solid diets.
Increased Fall Risk: Encourage use of assistive devices and implement safety precautions.
Cognition Monitoring: Depression and cognitive impairment need regular assessments; psychotherapeutic interventions possible.
Parkinson’s Disease may lead to Parkinsonism, a syndrome that presents symptoms similar to Parkinson’s but can arise from other conditions.
Medications:
Dopaminergics: Levodopa and carbidopa as primary treatment; manage symptoms by increasing dopamine availability.
Adverse Effects: Long-term use may lead to dyskinesias, involuntary movements that interfere with daily living; this may necessitate periodic adjustments to medication dosage.
Other Drug Classes: Include dopamine agonists, anticholinergics, COMT inhibitors, MAOIs, and antivirals; each plays a role in symptom management.
Surgical Procedures:
Deep Brain Stimulation (DBS): Implanting electrodes to stimulate dopamine production areas; may allow reduction of medication doses; effectiveness varies based on patient individuality.
Ablative Procedures: Thalamotomy and pallidotomy less common due to risks; used in specific cases where DBS is not an option.
Medication Administration: Regular dosages tailored to patient response; monitor for effectiveness and side effects.
Monitoring and Support: Assess swallowing, nutrition, mobility, and mental status; work closely with speech and occupational therapy.
Dietary Needs: Encourage small, frequent meals and high-calorie foods to combat weight loss due to difficulties in eating.
Mobility Enhancement: Regular exercise and physical therapy to stimulate muscle strength and balance; adaptive equipment may be beneficial.
Communication Strategies: Remind patients to speak clearly and face listeners, utilize speech therapy for specific exercises; consider communication aids if needed.
Parkinson's Disease:
Definition: Slowly progressing neurologic movement disorder leading to disability.
Prevalence: Affects about 1 million patients in the U.S. annually; more common in men than women; typically diagnosed around age 50.
Symptoms: Four cardinal symptoms include tremor, rigidity, bradykinesia/akinesia, and postural instability.
Complications: Monitor for swallowing difficulties, fall risk, and cognitive impairments.
Treatment: Understand medications like dopaminergics (e.g., levodopa/carbidopa), surgical procedures like Deep Brain Stimulation (DBS), and nursing interventions such as mobility enhancement and dietary needs.
Multiple Sclerosis:
Definition: Chronic autoimmune disorder affecting the CNS, with variable symptoms based on the type (Relapsing-Remitting, Primary Progressive, etc.).
Symptoms: Common symptoms include fatigue, ataxia, visual changes, and cognitive issues.
Diagnosis: MRI findings show plaques in the CNS, and cerebrospinal fluid analysis detects oligoclonal banding.
Treatment: Focus on disease-modifying drugs and symptomatic treatments; understand the importance of patient education on management.
Nursing Interventions:
Assess swallowing, nutrition, mobility, and mental status; work closely with rehabilitation services.
Emphasize patient education and support for daily activities, promoting independence while managing symptoms.